Back

DLG2-DLG4 expression in lower-grade glioma is associated with improved survival and an excitatory synaptic transmission and plasticity gene signature

Gaia, F.; Dal-Pizzol, H. R.; Malafaia, O.; Roesler, R.; Isolan, G. R.

2026-04-15 cancer biology
10.64898/2026.04.13.718176 bioRxiv
Show abstract

Background/ObjectivesIncreasing evidence indicates that gliomas co-opt mechanisms of excitatory synaptic transmission and plasticity to support tumor progression, yet these processes remain poorly characterized in lower-grade gliomas (LGGs). Here, we investigated whether genes associated with excitatory synaptic function are linked to patient prognosis in LGG. MethodsA curated panel of 36 synaptic genes was analyzed in LGG using RNA-sequencing and clinical data from The Cancer Genome Atlas (TCGA) and Chinese Glioma Genome Atlas (CGGA) datasets. Correlations among gene expression levels were analyzed using the Evergene platform. ResultsAmong the genes investigated, DLG2, DLG3, and DLG4, which encode the postsynaptic scaffolding proteins PSD-93, SAP-102, and PSD-95, respectively, showed strong associations with patient overall survival (OS). Higher expression of each gene was consistently associated with longer OS across both datasets. Expression of DLG2-DLG4 was higher in oligodendroglioma and IDH-mutant, 1p/19q co-deleted tumors, and lower in astrocytoma and IDH-wild-type tumors. Furthermore, expression of all three genes positively correlated with a broad gene signature related to excitatory synaptic transmission and synaptic plasticity, including multiple components of glutamatergic signaling and postsynaptic organization. ConclusionsThese findings suggest that elevated expression of DLG2-DLG4 is associated with a transcriptional program resembling differentiated neuronal-like features and favorable clinical outcome in LGG. Simple SummaryLower-grade gliomas are brain tumors with highly variable outcomes, and better markers are needed to predict how patients will fare. Recent research suggests that these tumors may use mechanisms normally involved in communication between brain cells, but this is not well understood in these cancer types. In this study, we analyzed large patient datasets to examine genes related to synaptic function. We found that higher expression of three genes involved in synaptic membrane organization, DLG2, DLG3, and DLG4 was consistently associated with longer patient survival. These genes were also linked to a broader pattern of gene expression suggestive of neural transmission and plasticity. Our findings suggest that some lower-grade gliomas may adopt characteristics of normal brain cells that are associated with less aggressive behavior. This work may help guide future research on prognostic markers and improve understanding of brain tumor biology.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
Neuro-Oncology
30 papers in training set
Top 0.1%
34.1%
2
Neuro-Oncology Advances
24 papers in training set
Top 0.1%
19.2%
50% of probability mass above
3
PLOS ONE
4510 papers in training set
Top 24%
7.0%
4
Cancers
200 papers in training set
Top 2%
2.7%
5
Brain
154 papers in training set
Top 2%
2.7%
6
Acta Neuropathologica Communications
81 papers in training set
Top 0.3%
2.5%
7
npj Precision Oncology
48 papers in training set
Top 0.4%
2.0%
8
BMC Cancer
52 papers in training set
Top 1%
1.8%
9
Scientific Reports
3102 papers in training set
Top 54%
1.8%
10
Clinical Epigenetics
53 papers in training set
Top 0.5%
1.8%
11
Neoplasia
22 papers in training set
Top 0.2%
1.8%
12
OncoImmunology
22 papers in training set
Top 0.2%
1.3%
13
Journal of the Neurological Sciences
17 papers in training set
Top 0.4%
1.3%
14
Frontiers in Genetics
197 papers in training set
Top 7%
1.1%
15
Computers in Biology and Medicine
120 papers in training set
Top 3%
1.1%
16
Journal of Clinical Investigation
164 papers in training set
Top 5%
1.1%
17
PeerJ
261 papers in training set
Top 11%
1.0%
18
Interface Focus
14 papers in training set
Top 0.2%
1.0%
19
F1000Research
79 papers in training set
Top 3%
0.9%
20
BMC Medicine
163 papers in training set
Top 7%
0.8%
21
Glia
74 papers in training set
Top 0.5%
0.8%
22
Neurobiology of Disease
134 papers in training set
Top 4%
0.8%
23
International Journal of Cancer
42 papers in training set
Top 1%
0.7%
24
ASN Neuro
10 papers in training set
Top 0.1%
0.7%